GMC Life Sciences Fund By Praetura

"We’re building a future where everyone has the tools and confidence to take control of their health — wherever they are. This funding allows us to scale our digital platform, extend our reach into new communities, and strengthen our collaborations and integrations across employer, public health and primary care. Prevention has to be proactive, accessible and data-informed — and that’s exactly what SiSU Health delivers."

"Following a period of intensive development, during which we priortised quality, our customers’ needs and patient outcomes, I am delighted to see Pill Connect move into commercial adoption. Our dispensers are now being used in clinical trials, ensuring that one of the most critical factors – the drug being taken – is now both measurable and can be acted upon during a clinical trial."

"We understood CareLoop’s mission, vision for transforming severe mental illness aftercare and the wider roadmap from our very first meeting with the team. Fast-forward to the present day and we’re incredibly excited to not only be supporting the company with investment but also the more than money guidance and network support it needs to scale and deploy its technology across the NHS and other global health institutions. The company is a testament to the quality of spinouts coming out of the University of Manchester, and the North West’s universities more generally. In addition, it’s great to see the GMC Life Sciences Fund by Praetura and the NPIFII – Praetura Equity Finance funds collaborate alongside co-investors from the UK and Singapore."

"Re:course AI has the potential to disrupt how the healthcare professionals of the future are trained, as the demand for virtual AI-based training is growing,"